Hydronephrosis Associated with Cervical Cancer Case Report on Pathophysiology, Diagnosis, and Management
DOI:
https://doi.org/10.12775/QS.2024.26.55041Keywords
cervical cancer, hydronephrosis, percutaneous nephrostomy, ureteral stentingAbstract
Introduction and Purpose
Cervical cancer is one of the most common malignancies in women, accounting for the fourth most common cancer worldwide and the sixth in Poland. Despite advances in diagnosis and prevention, the condition is still associated with a high mortality rate, especially in advanced stages. One of the significant complications of advanced cervical cancer is hydronephrosis, occurring in about 23% of patients. Hydronephrosis develops as a result of blocked urine outflow, which leads to stretching of the renal calyces and can result in renal failure if not properly treated. Management strategies for hydronephrosis include ureteral stenting and percutaneous nephrostomy, both of which are effective in draining the kidneys and improving patient outcomes.
Aim of the study
This article discusses the pathophysiology, diagnosis and treatment of hydronephrosis in patients with cervical cancer, and presents a detailed case report of a patient with advanced cervical cancer complicated by hydronephrosis and renal perforation.
Results and Future directions
The patient was admitted to the urology department for bleeding into the retroperitoneal space after renal fistula replacement. During hospitalization, despite numerous complications, the patient's condition stabilized after blood and plasma transfusions, intensive antibiotic therapy and renal fistula re-implantation. The final results of the treatment were successful, and the patient was discharged with appropriate recommendations. The study highlights the importance of early diagnosis and effective treatment of hydronephrosis to improve the prognosis of patients with cervical cancer. It underscores the need for multidisciplinary collaboration involving urologists, oncologists and other specialists to provide comprehensive care tailored to the patient's evolving needs.
References
Johnson CA, James D, Marzan A, Armaos M. Cervical Cancer: An Overview of Pathophysiology and Management. Semin Oncol Nurs. 2019;35(2):166-174. doi:10.1016/j.soncn.2019.02.003
dr hab. n. med. Paweł Blecharz, Rak szyjki macicy: przyczyny, objawy, leczenie i szczepienie, Available from: https://www.mp.pl/pacjent/onkologia/chorobynowotworowe/99295,rak-szyjki-macic
Sahasrabuddhe VV. Cervical Cancer: Precursors and Prevention. Hematol Oncol Clin North Am. 2024;38(4):771-781. doi:10.1016/j.hoc.2024.03.005
Rak szyjki macicy Aktualizacja w 2021 roku, Available from:
https://www.onkonet.pl/dp_nnr_rakszyjkimacicy.php
Jan Zieliński, Rak szyjki macicy (r.sz.m.)/Cervical carcinoma, Czytelnia Medyczna, Nowa Medycyna, 5-6/2001, Available from:
https://www.czytelniamedyczna.pl/3252,rak-szyjki-macicy-rszm.html
Martínez-Rodríguez F, Limones-González JE, Mendoza-Almanza B, et al. Understanding Cervical Cancer through Proteomics. Cells. 2021;10(8):1854. Published 2021 Jul 22. doi:10.3390/cells10081854
Khulpateea BR, Paulson A, Carlson M, Miller DS, Lea J. Stage IVA cervical cancer: outcomes of disease related complications and treatment. Int J Gynecol Cancer. 2021;31(4):518-523. doi:10.1136/ijgc-2019-000386
Wit EM, Horenblas S. Urological complications after treatment of cervical cancer. Nat Rev Urol. 2014;11(2):110-117. doi:10.1038/nrurol.2013.323
Patel K, Foster NR, Kumar A, et al. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015;23(5):1303-1309. doi:10.1007/s00520-014-2482-y
Li J, Cao H, Peng K, Chen R, Sun X. Hydronephrosis in patients with cervical cancer: An improved stent-change therapy for ureteral obstruction Stent-change for ureteral obstruction in cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2023;283:49-53. doi:10.1016/j.ejogrb.2023.01.026
Tan S, Tao Z, Bian X, et al. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2019;241:99-103. doi:10.1016/j.ejogrb.2019.08.020
Yang YR, Chen SJ, Yen PY, et al. Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study. Medicine (Baltimore). 2021;100(6):e24182. doi:10.1097/MD.0000000000024182
Warli SM, Tala MRZ, Wijaya WS. Predictive Factors of Successful Double J Stent Insertion Among Advanced Cervical Cancer Patients. World J Oncol. 2024;15(2):239-245. doi:10.14740/wjon1631
Dhani FK, Daryanto B, Seputra KP. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis. Asian Pac J Cancer Prev. 2023;24(8):2641-2646. Published 2023 Aug 1. doi:10.31557/APJCP.2023.24.8.2641
Nóbrega L, Zanon JR, Andrade CEEMDC, Schmidt RL, Dos Santos MH, Dos Reis R. Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort. Int J Gynecol Cancer. Published online August 16, 2022. doi:10.1136/ijgc-2022-003679
Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc. 2020;112(2):229-232. doi:10.1016/j.jnma.2020.03.002
Li H, Wu X, Cheng X. Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 2016;27(4):e43. doi:10.3802/jgo.2016.27.e43
Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2010;117(2):270-275. doi:10.1016/j.ygyno.2010.01.045
Chao KS, Leung WM, Grigsby PW, Mutch DG, Herzog T, Perez CA. The clinical implications of hydronephrosis and the level of ureteral obstruction in stage IIIB cervical cancer. Int J Radiat Oncol Biol Phys. 1998;40(5):1095-1100. doi:10.1016/s0360-3016(97)00899-7
Atuhairwe S, Busingye RB, Sekikubo M, Nakimuli A, Mutyaba T. Urologic complications among women with advanced cervical cancer at a tertiary referral hospital in Uganda. Int J Gynaecol Obstet. 2011;115(3):282-284. doi:10.1016/j.ijgo.2011.07.021
Shah M, Blest F, Blackmur J, Laird A, Dawson S, Aning J. Malignant upper urinary tract obstruction in cancer patients: A systematic review. BJUI Compass. 2024;5(5):405-416. Published 2024 Feb 27. doi:10.1002/bco2.340
Alexa R, Kranz J, Kramann R, et al. Harnessing Artificial Intelligence for Enhanced Renal Analysis: Automated Detection of Hydronephrosis and Precise Kidney Segmentation. Eur Urol Open Sci. 2024;62:19-25. Published 2024 Feb 22. doi:10.1016/j.euros.2024.01.017
Serel A, Ozturk SA, Soyupek S, Serel HB. Deep Learning in Urological Images Using Convolutional Neural Networks: An Artificial Intelligence Study. Turk J Urol. 2022;48(4):299-302. doi:10.5152/tud.2022.22030
National Guideline Centre (UK). Timing of surgery: Renal and ureteric stones: assessment and management. London: National Institute for Health and Care Excellence (NICE); January 2019.
National Guideline Centre (UK). Stents before surgery: Renal and ureteric stones: assessment and management. London: National Institute for Health and Care Excellence (NICE); January 2019.
National Guideline Centre (UK). Stents after surgery: Renal and ureteric stones: assessment and management. London: National Institute for Health and Care Excellence (NICE); January 2019.
Geavlete P, Georgescu D, Mulțescu R, Stanescu F, Cozma C, Geavlete B. Ureteral stent complications - experience on 50,000 procedures. J Med Life. 2021;14(6):769-775. doi:10.25122/jml-2021-0352
Branger N, Lorusso V, Pacchetti A, et al. Impact of long-term indwelling JJ stent on renal volume and renal function. Minerva Urol Nephrol. 2023;75(6):752-760. doi:10.23736/S2724-6051.22.04975-8
Washida H, Tsugaya M, Hirao N, Sakagami H, Iwase Y. Hinyokika Kiyo. 1986;32(3):413-421.
DE Lorenzis E, Zanetti SP, Boeri L, Albo G, Montanari E. Long-term ureteral JJ stent: useful, useless or harmful?. Minerva Urol Nephrol. 2023;75(6):667-671. doi:10.23736/S2724-6051.23.05541-6
Damian FB, de Almeida FK, Fernandes FS, Jimenez MF. Impact of hydronephrosis and kidney function on survival in newly diagnosed advanced cervical cancer. Gynecol Oncol Rep. 2022;39:100934. Published 2022 Jan 22. doi:10.1016/j.gore.2022.100934
Goklu MR, Seckin KD, Togrul C, et al. Effect of hydronephrosis on survival in advanced stage cervical cancer. Asian Pac J Cancer Prev. 2015;16(10):4219-4222. doi:10.7314/apjcp.2015.16.10.4219
Pergialiotis V, Bellos I, Thomakos N, et al. Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature. Oncol Rev. 2019;13(1):387. Published 2019 Jan 15. doi:10.4081/oncol.2019.387
Nakamura H, Ko K, Kiseki H, Ikeda SI. Renal Subcapsular Hematoma Formation Due to Hydronephrosis Caused by Recurrent Uterine Cervical Cancer. J Med Cases. 2021;12(3):126-129. doi:10.14740/jmc3640
Sowunmi AC, Ajekigbe AT, Alabi AO, Popoola AO, Fatiregun OA, Akinyanju AM. Incidence of Hydronephrosis in Cervical Cancer Patients in A Tertiary Hospital Lagog, Nigeria. Nig Q J Hosp Med. 2015;25(3):171-176.
Brandt MP, Lehnert T, Czilwik T, et al. CT-guided nephrostomy-An expedient tool for complex clinical scenarios. Eur J Radiol. 2019;110:142-147. doi:10.1016/j.ejrad.2018.11.028
Smith PE, Luong ITH, van der Vliet AH. CT-guided nephrostomy: Re-inventing the wheel for the occasional interventionalist. J Med Imaging Radiat Oncol. Published online March 12, 2018. doi:10.1111/1754-9485.12720
Thanos L, Mylona S, Stroumpouli E, Kalioras V, Pomoni M, Batakis N. Percutaneous CT-guided nephrostomy: a safe and quick alternative method in management of obstructive and nonobstructive uropathy. J Endourol. 2006;20(7):486-490. doi:10.1089/end.2006.20.486
Li F, Guo H, Qiu H, et al. Urological complications after radical hysterectomy with postoperative radiotherapy and radiotherapy alone for cervical cancer. Medicine (Baltimore). 2018;97(13):e0173. doi:10.1097/MD.0000000000010173
Dyer RB, Regan JD, Kavanagh PV, Khatod EG, Chen MY, Zagoria RJ. Percutaneous nephrostomy with extensions of the technique: step by step. Radiographics. 2002;22(3):503-525. doi:10.1148/radiographics.22.3.g02ma19503
Zhang KP, Zhang Y, Chao M. Which is the best way for patients with ureteral obstruction? Percutaneous nephrostomy versus double J stenting. Medicine (Baltimore). 2022;101(45):e31194. doi:10.1097/MD.0000000000031194
Cozma C, Georgescu D, Popescu R, Geavlete B, Geavlete P. Double-J stent versus percutaneous nephrostomy for emergency upper urinary tract decompression. J Med Life. 2023;16(5):663-667. doi:10.25122/jml-2022-0334
Szvalb AD, El Haddad H, Rolston KV, et al. Risk factors for recurrent percutaneous nephrostomy catheter-related infections. Infection. 2019;47(2):239-245. doi:10.1007/s15010-018-1245-y
Zul Khairul Azwadi I, Norhayati MN, Abdullah MS. Percutaneous nephrostomy versus retrograde ureteral stenting for acute upper obstructive uropathy: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6613. Published 2021 Mar 23. doi:10.1038/s41598-021-86136-y
Gonçalves MS, Adragão T, Negrão AP, Simões JJ. Interesse da nefrostomia percutânea em nefrologia [Value of percutaneous nephrostomy in nephrology]. Acta Med Port. 1992;5(10):533-537.
Trifunovski A, Severova G, Atanasova A, et al. Percutaneous Nephrostomy as a Procedure in the Treatment of Urinary Tract Obstruction - Experiences in the University Clinic of Urology in Skopje. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2024;45(1):31-40. Published 2024 Apr 4. doi:10.2478/prilozi-2024-0004
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Kacper Stolarek, Emilia Kowalczyk, Mateusz Szarek, Alicja Andrzejak, Hubert Olszewski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 55
Number of citations: 0